Goodman BE. Channels active in the excitability of nerves and skeletal muscles across the neuromuscular junction: basic function and pathophysiology.
TEACHERS OF PHYSIOLOGY spend significant amounts of time explaining to their students how nerves and muscles generate and carry electrical signals and use their excitability to perform their basic functions. Excitable cells (nerve, heart, skeletal, and smooth muscle cells) are characterized by having a high number of voltage-gated ion channels and using propagating action potentials to initiate their responses. In contrast, nonexcitable cells (epithelial, skin, liver, and salivary gland cells) have few voltage-gated ion channels and generally use only small changes in membrane potential (generator potentials) to initiate their responses. For an indepth understanding of neuromuscular excitable cell functions, necessary knowledge includes ion fluxes involved in standard neuronal action potentials, in excitation-secretion coupling at the axon terminal, and in the stimulation of the skeletal muscle fiber after ACh for excitation-contraction coupling. While these channel activities may be fascinating to cell physiologists, the relevance of these cellular events for students may be strengthened by involving students in figuring out how various mutations and autoantibodies will directly result in serious pathological situations for the affected individuals. This Staying Current article seeks to clarify which ion fluxes through which channels are involved in the generation of action potentials in neurons, synaptic transmission, and stimulation of contraction in skeletal muscles and how defects in certain channels (channelopathies) can lead to further understanding of channel functions and dysfunctions.
Primer on Neuronal Action Potentials
As described in numerous physiology textbooks (4), the resting membrane potential of mammalian neurons is about Ϫ70 mV. When an input signal occurs, mechanically, chemically, or voltage-gated channels (usually Na ϩ , Cl Ϫ , or Ca 2ϩ ) open to lead to a graded potential at the dendrites or the cell body. If the graded potential is sufficient (when it arrives at the trigger zone of the axon hillock) to depolarize the membrane to threshold (Ϫ55 mV), voltage-gated Na ϩ channels rapidly open, and Na ϩ rushes into the cell (Fig. 1 ). Rapid Na ϩ entry depolarizes the cell, and the membrane potential approaches the Nernst equilibrium potential for Na ϩ (E Na ) of ϩ67 mV (9) . This causes the depolarizing or rising phase of the action potential. The positive membrane potential (above 0 mV) is sometimes called the overshoot. Voltage-gated Na ϩ channels are both fast activating and fast inactivating and thus close quickly (at about ϩ30 mV) before E Na is reached (9) . Voltage-gated K ϩ channels, which take slightly longer than voltage-gated Na ϩ channels to open, begin to open and allow K ϩ to move out of the cell. As K ϩ leaves the cell, the membrane potential rapidly becomes more negative. This causes the repolarizing or falling phase of the action potential and sends the membrane potential back toward the resting membrane potential. Voltage-gated K ϩ channels and other K ϩ channels remain open, and the membrane potential undershoots the resting value, approaching the Nernst equilibrium potential for K ϩ (E K ) of Ϫ98 mV (9) . This phase is called the afterhyperpolarization (AHP). Finally, voltage-gated K ϩ channels close, and small ion fluxes return the membrane potential to its resting value. Macroscopic ion fluxes depend on the number of individual ion-selective channels present in the cell, the probability that those channels are open at any time, and the conductance of individual channels, all of which may vary and depend on the potential difference across the membrane.
The stars of the basic description of the ion fluxes responsible for the neuronal action potential are voltage-gated Na ϩ and K ϩ channels; however, other K ϩ channels and small ion fluxes are known to be involved in the return of the membrane potential to resting during the AHP phase from either single action potentials or after a series of action potentials. The maintenance of resting membrane potentials in the steady state for neurons also depends primarily on small fluxes of Na ϩ , K ϩ , and Cl Ϫ through their channels. At resting membrane potential, axonal ion channels tend to be closed, thus minimizing fluxes. Resting membrane potential is best estimated using the Goldman-Hodgkins-Katz equation, which incorporates the differential permeabilities and concentration differences across cell membranes for Na Mutations in genes for channel proteins may lead to changes in the resting membrane potentials of neurons or muscle cells and result in pathophysiology, leading to neuromuscular diseases and disorders. Thus, an understanding of the actions of various types of channels involved in the physiology of excitable cells is helpful for interpreting how certain channelopathies affect neuromuscular function.
Voltage-Gated Na ϩ Channels and the Neuronal Action Potential
Voltage-gated Na ϩ channels are responsible for the rapid depolarization of a neuron causing an action potential (4) (Fig.  1) . Voltage-gated Na ϩ channels are very voltage sensitive, and their open probability is very low at the resting membrane potential. Thus, few Na ϩ ions move across neuronal cell membranes during resting. A depolarizing stimulus increases the probability of individual Na ϩ channels opening, and the open probability of the channel is strongly time dependent. Thus, Na ϩ channels open briefly after a short delay and then rapidly close again (4) . Greater than 95% of the individual Na ϩ channels are closed by the time the membrane is depolarized to 0 mV or above (9) . Voltage-gated Na ϩ channels are relatively selective for the flux of Na ϩ over K ϩ and other monovalent cations and are essentially impermeable to Ca 2ϩ and other divalent cations. Their protein structure includes a pore-forming ␣-subunit and two membrane-spanning ␤-subunits, which are likely to be involved in modulating channel gating or channel expression (4) (Fig. 2) . Mutations in any of the eight homologous genes that encode for ␣-subunits in various excitable cells are known to lead to genetic defects in Na ϩ channels. Voltage-gated Na ϩ channels are composed of activation and inactivation gates that alternate between keeping the channel open and closed. A common model of the gating activity in an individual voltage-gated Na ϩ channel during the action potential has the activation gate (internal to the pore) closed at the Mutations known to cause hyperkalemic periodic paralysis are in round-edged boxes; mutations known to cause paramyotonia congenita are in circles; mutations known to cause K ϩ -aggravated myotonia are in sharpedged boxes. [From Ref. 12.] resting membrane potential and then opened by a depolarizing stimulus. When the activation gate is open, Na ϩ flows into the neuron. As the cell is depolarized toward E Na , the inactivation gate closes, and Na ϩ entry rapidly stops. Voltage-gated Na ϩ channels display two modes of inactivation: fast and slow. Fast inactivation is likely due to a structure similar to a rigid hinged lid on the cytoplasmic side of the protein that controls access to the pore and is latched closed during inactivation (1) . Slow inactivation likely results from rearrangement of the pore (7).
Delayed Rectifier Voltage-Gated K ϩ Channels and the Neuronal Action Potential
These voltage-gated K ϩ channels are responsible for the repolarization (falling phase) of an action potential in a neuron (4) (Fig. 1) . Also known as K v class (or Shaker-related) K ϩ channels, they have strong selectivity for K ϩ over other cations (9) . Mammalian neuronal voltage-gated K ϩ channels are made up of four ␣-subunits and one cytoplasmic ␤-subunit (Fig. 3) . Their primary role in excitable cells is inhibitory because when they are open, K ϩ tends to leave the cell, making the inside less positive (more negative) and approach E K . Thus, they stabilize the membrane potential by bringing the membrane potential closer to E K and farther away from firing threshold (9) . Therefore, voltage-gated K ϩ channels in excitable cells determine the resting membrane potential, decrease the time duration of action potential spikes, time the interspike intervals during repetitive firing, and make it more difficult to bring neurons to threshold when they are open (9) .
These channels are known as delayed (outward) rectifier K ϩ channels because they change membrane conductance with a delay after a depolarizing voltage (even though most other channels also have a delay) and K ϩ passes in an outward direction toward the extracellular fluid (4). Various K ϩ channels have different degrees of delayed rectification when their voltage-sensing segment detects that the neuron is depolarized. They open after short depolarization but eventually close with long depolarization. It is likely that cytoplasmic ball-and-chain portions of these protein channels from either ␣-subunits alone or from adjacent ␤-subunits block the pore to stop K ϩ fluxes and inactivate individual channels (Fig. 3) . Three different families of seventeen distinct genes are known to be involved in encoding excitable cell K ϩ channels, and their mutations cause several identified channelopathies (4) . Different types of delayed rectifier K ϩ channels are found in vertebrate nerves, the heart, and skeletal muscle, and they are encoded by different genes (9) . Loss of function mutations (mutations that cause channels to conduct fewer ions) in voltage-gated K ϩ channels prolong the duration of the action potential (2).
Cl

Ϫ Channels and the Neuronal Action Potential
Cells are known to have anion-selective channels that readily allow the passage of Cl Ϫ , Br
, HCO 3 Ϫ , and SCN Ϫ (9). Cl Ϫ is commonly distributed almost at its electrochemical equilibrium (Nernst equilibrium potential for Cl Ϫ ϭ Ϫ90 mV) across excitable cell membranes so that the extra-
. Depolarization of an excitable cell produces an influx of Cl Ϫ (anions tend to accompany the movement of cations across the cell membrane to maintain electroneutrality). Thus, Cl Ϫ channels oppose excitability by limiting the depolarizing stimulus, help to return a depolarized cell to resting, and thus stabilize the membrane potential of excitable cells (Fig. 1) . The characterization and cloning of Cl Ϫ channels have not progressed as far as those of other ion channels involved in excitable cell function (voltage-gated Na ϩ , K ϩ , and Ca 2ϩ channels); however, Cl Ϫ fluxes are particularly important for stabilizing the Fig. 3 . Three-dimensional drawing of a voltage-gated K ϩ channel with one subunit of a tetramer missing to show inside structure. Helixes are the voltage sensors. The NH 2 -terminus is a ball-and-chain inactivation structure. [From Ref. 13.] resting membrane potential in skeletal muscle (9) (Fig. 4) .
When mutations in Cl
Ϫ channels lead to an absence of this stabilizing influence of Cl Ϫ fluxes, skeletal muscle is hyperexcitable, as seen in myotonia congenita.
Other K ϩ Channels and the Neuronal Action Potential
Inwardly rectifying K ϩ channels (K ir channels) have been identified in human motor axons. They are activated by hyperpolarization, leading to inward fluxes of K ϩ that depolarize the axon and bring the membrane potential back toward the resting membrane potential (15) . K ir channels open after ϳ30 ms following an action potential and reach steady state over 100 -200 ms (15) . Thus, they are involved in the last phase of recovery toward resting membrane potential following an action potential or series of action potentials (Fig. 1) . Their two major physiological roles are stabilizing the resting potential near E K and assisting with transport of K ϩ across cell membranes. All K ir channels show some degree of inward rectification, which is variable due to a voltage-dependent block by intracellular cations obstructing the mouth of the channel pore (1) . The normal function of inward rectifiers is likely to carry outward current because the membrane potential of animal cells is rarely more negative than E K . Thus, inward rectifiers also carry some outward current (9) . The function of inward rectifiers in fast skeletal muscle may be to accelerate the reentry of K ϩ from the t-tubular space after action potentials. At least 16 genes encode for K ir channels, which are likely found in the cell membrane as tetramers of individual subunits (9) . Each K ir monomer has two transmembrane spanning domains. Mutations in K ir channels or changes in the regulation of K ir channels have been implicated in causing neuronal degeneration. Ca 2ϩ -dependent K ϩ (K Ca ) channels are activated by both depolarization and increases in intracellular free [Ca 2ϩ ]. K Ca currents contribute to the repolarization of neurons to resting membrane potential and are involved in the AHP phase of the action potential. After the action potential spike of a motoneuron, there is an initial fast AHP that lasts 1-2 ms and a later slow AHP lasting 50 -100 ms (9) (Fig. 1) . The fast AHP is due to voltage-gated K ϩ channels that opened during the spike and then rapidly closed. The slow AHP is due to K ϩ effluxes from the cells through slow K ϩ channels activated by Ca 2ϩ influxes during the action potential and lasts while intracellular Ca 2ϩ is elevated. Thus, K Ca channels determine the shape of the action potential and help in regulating cell excitability. To date, no human neuromuscular disease or disorder has been identified as specifically related to defects in K Ca channels. K Ca channels have been designated as one of three major types based on their single channel conductances. The maxi K Ca channel (also known as the BK Ca channel) has large single channel conductance (100 -250 pS without a concentration gradient) and is activated by depolarization and micromolar [Ca 2ϩ ]. is removed (9) .
In an oxygen-deprived cell where intracellular ATP levels fall, ATP-sensitive K ϩ (K ATP ) channels open to hyperpolarize the cell, suppress firing of action potentials, and reduce the use of cellular energy (1). K ATP channels open to allow K ϩ effluxes when there is no cytoplasmic ATP, some are closed when there are moderate levels of ATP, and most are closed when there are high levels of ATP. K ATP channels have been identified in nerves, the heart, and skeletal muscle, but their physiological functions are unclear. However, recent evidence has indicated that the inhibition of K ATP channels in highaltitude hypoxia may be involved in causing high altitude pulmonary edema (11) . K ATP channels are most commonly studied for their role in pancreatic ␤-cells, where at low nutrient levels they inhibit the release of insulin into the bloodstream (9) .
Slow delayed rectifiers of the slowly gating KCNQ class of K ϩ channels are expressed in neurons and regulated by neurotransmitters (1). They appear to gate too slowly to be activated by individual action potentials; however, tonically open KCNQ channels leading to K ϩ effluxes would help to decrease Fig. 4 . Hydropathy plot of a voltage-gated Cl Ϫ channel in skeletal muscle. Mutations shown in rectangles are known to underlie Becker's myotonia congenita, and those shown in circles are known to cause Thomsen's myotonia congenita. [From Ref. 12.] excitability by keeping the resting membrane potential away from threshold (9) .
Primer on Neuronal Action Potential Arriving at Neuromuscular Junction
Following repetitive changes in ion fluxes across the axonal cell membrane through the various types of channels described above, a series of all-or-nothing action potentials reaches the axon terminal at the synapse of the neuromuscular junction (1). The arrival of the action potentials depolarizes the membrane at the axon terminal, opens voltage-gated Ca 2ϩ channels located there, and allows Ca 2ϩ to enter the neuron. Voltage-gated Ca 2ϩ channels have been classified as L, N, P, Q, R, and T types and are normally distinguished by their sensitivity to pharmacological blockers, their characteristic single channel conductances, their kinetics, and their degree of voltage dependence (1). For example, T-type voltage-gated Ca 2ϩ channels have low thresholds of activation, allowing them to open with small levels of depolarization. They inactivate rapidly and completely when the membrane potential becomes positive. In contrast, the L-, N-, P-, Q-, and R-type channels require much stronger levels of depolarization to open. Pharmacologically, L-type channels are blocked by dihydropyridines, and N-type channels are blocked by toxins from fish-hunting cone snails. A toxin from a funnel web spider blocks both P-and Q-type channels but with different affinities. P/Q types of voltagegated Ca 2ϩ channels are present at presynaptic nerve terminals and appear to be the most important channels for the excitation-secretion coupling of ACh release at the neuromuscular junction. Ca 2ϩ channels are functionally similar to Na ϩ channels except that high-affinity binding of Ca 2ϩ inside the pore makes them extremely selective for Ca 2ϩ over monovalent cations (4). At least seven different genes coding for ␣ 1 -subunits of voltage-gated Ca 2ϩ channels have been identified (1).
Primer on How the Neurotransmitter ACh Activates Muscle
ACh is released from the presynaptic motor neuron into the synapse based on excitation-secretion coupling facilitated by P/Q-type voltage-gated Ca 2ϩ channels (1). These neurotransmitter molecules diffuse across the 20-to 30-nm synaptic cleft and interact with nicotinic ACh receptor (AChR) channels clustered in junctional folds across from the axon terminal on the muscle cell membrane (also known as the end plate). The AChR is known to be a pentamer of homologous subunits arranged in a ring around a central ion pore (1) . When two ACh molecules bind to an AChR, a conformational change in the receptor opens the central pore and allows cations to flow into or out of the muscle cell. Since generally (due to electrochemical gradients) more Na ϩ flows in than K ϩ leaves, the muscle cell is depolarized. If enough ACh is released, then sufficient AChR channels are activated and the muscle cell membrane is depolarized to threshold for opening the voltage-gated Na ϩ channels nearby and initiating a muscle action potential. Generally, stimulation of a motoneuron automatically releases enough ACh into the cleft to stimulate the adjacent muscle cell to threshold. Thus, an action potential (with similar ion fluxes to the neuronal action potential) is initiated at the postsynaptic site on the muscle cell membrane.
Primer on Muscle Action Potentials Spreading Down t-Tubules and Activating Ca 2ϩ Channels
Action potentials originating after a muscle cell is depolarized to threshold propagate along the skeletal muscle membrane and down t-tubules (4). The action potential membrane depolarization opens L-type voltage-gated Ca 2ϩ channels in the t-tubule membrane. These L-type Ca 2ϩ channels are also known as dihydropyridine receptors because they are inhibited by the class of antihypertensives known as dihydropyridines. Conformational changes in L-type Ca 2ϩ channels following depolarization allow Ca 2ϩ to enter the skeletal muscle sarcoplasm. The conformational change in L-type Ca 2ϩ channels induces a conformational change in an adjacent Ca 2ϩ -release channel located in the membrane of the sarcoplasmic reticulum (SR) of the muscle cell. The Ca 2ϩ -release channel is also known as the ryanodine receptor because it is inhibited by the plant alkaloid ryanodine. When the L-type Ca 2ϩ channel on the t-tubule membrane mechanically opens the Ca 2ϩ -release channel in the SR, Ca 2ϩ sequestered in the SR rapidly leaves via Ca 2ϩ -release channels, binds to troponin C on the actin myofilament, and leads to the initiation of cross-bridge cycling of the muscle in the process known as excitation-contraction coupling (34).
Pathologies of Ion Channel Function in Nerves and Skeletal Muscles
Over 340 human genes are thought to encode ion channels, and mutations in over 60 ion channel genes are known to cause human diseases (2) . Ion channels are a large family of Ͼ400 related proteins and make up ϳ1% of the human genome (6). Ion channel diseases were first recognized in 1989 with the discovery of the contribution of CFTR to the symptoms of cystic fibrosis. Ion channel diseases have come to be known as channelopathies and may arise in a number of different ways (1):
1. Mutations in the promoter region of an ion channel gene may lead to an underexpression or overexpression of channel proteins.
2. Mutations in the coding region of an ion channel gene may lead to gain or loss of channel function.
3. Mutations in genes encoding for regulatory molecules or for pathways leading to regulatory molecules may lead to defective regulation of channel activity by its intracellular or extracellular ligands or modulators.
4. Autoantibodies to channel proteins are made that may lead to downregulation or upregulation of channel function.
5. Ion channels may act as lethal agents to form large nonselective pores in the target cells leading to target cell lysis or death."
In the future, healthcare providers will be able to use diagnostic tests for genetic screening and prenatal diagnosis of various channelopathies. In addition, a clear understanding of the defect at the cellular level can facilitate design of selective drugs and treatment for affected individuals. Specific gene therapy by introducing normal genes or upregulating fetal genes to substitute for the genetic defect may help cure the defects. Translational research studying how various individuals with channelopathies exhibit symptoms and react to treatments have led to major breakthroughs in understanding the basic physiology of various ion channels and how they contribute to homeostasis. Interpreting at the cellular level what problems will be caused by a specific ion channel defect in a nerve or muscle can help to establish relevance for learning for students. Thus, the next section of this review will describe some ion channel mutations and changes for the channels already described and correlate the defects with changes in normal physiological function in nerve and muscle cells (Fig. 5 and Table 1 ). The APPENDIX at the end of the article helps to clarify some of the clinical definitions of the terms. To facilitate the learning process, think, pair, share questions to be used with students have been designed for a number of defects that lead to human diseases. Case studies or simulated drug design projects would also be interesting ways to introduce the channelopathies so that students can learn the relevance of these changes in channel function (3, 5, 13) . Diseases related to mutations in voltage-gated Na ϩ channels include hyperkalemic periodic paralysis, paramyotonia congenita, and K ϩ -aggravated myotonia (1) . Mutations in voltagegated Na ϩ channels cause diseases of skeletal muscle, and most are mutations that alter some aspect of channel inactivation. Na ϩ channels with these gain of function mutations fail to inactivate and conduct sustained inward Na ϩ fluxes (Fig. 2) . Such diseases are characterized by skeletal muscle hyperexcitability or muscle weakness that is exacerbated by an increase in extracellular [K ϩ ] or exposure to cold temperatures. The variability of the symptoms of the defect from hyperexcitability to weakness is due to the characteristic of Na ϩ channels whereby small membrane depolarizations lead to more excitable cells (as the membrane potential is closer to the threshold potential) and larger membrane depolarizations (above threshold) can lead to depolarization block, which results in one contraction followed by paralysis. Depolarization block likely occurs because individual voltage-gated Na ϩ channels never return to resting membrane potential to be reset for the opening of activation gates after the next depolarizing stimulus. Increased plasma K ϩ may precipitate an attack because the depolarization it causes keeps the defective Na ϩ channels open longer (1) . Cells that are more excitable generate repetitive action potentials that lead to myotonia (an inability to relax and thereby muscle stiffness) (10) . Myotonia can also result in fasciculations or visible rippling contractions of the muscles. One of these voltage-gated Na ϩ channel diseases known as hyperkalemic (elevated plasma K ϩ levels) periodic paralysis is characterized by short, mild, frequent attacks of profound muscle weakness, beginning in infancy, that can be provoked by rest after exercise or stress and often demonstrates myotonia between attacks (6). Both myotonia and paralysis can occur in the same patient within a few minutes of each other (1) . Attacks are either spontaneous or precipitated by exercise, stress, fasting, or eating K ϩ -rich food (bananas). Periodic paralyses and myotonias are generally painless and not life threatening, although they can be very inconvenient. They are unlikely to affect the respiratory muscles and cause difficulty in breathing (1). Paramyotonia congenita is characterized by a cold-exacerbated myotonia (1) and results in very unpleasant stiffening of muscles that happens when working in the cold. The muscle stiffness results from continued firing of action potentials in muscles after the cessation of voluntary effort or stimulation (1) . Patients may also have muscle hypertrophy (overdevelopment) as a consequence of the continuous muscle activity. K ϩ -aggravated myotonia is characterized by muscle stiffness mostly when muscles are used after a period of rest (1). Three diseases that have been identified to be due to mutations in neuromuscular K ϩ channels include episodic ataxia type 1, Andersen's syndrome, and acquired neuromyotonia (see Autoantibodies Affecting Neuromuscular Transmission) (1) . Episodic ataxia type 1 affects peripheral and central nerves, causing attacks of imbalance and uncoordinated movements often with nausea, vertigo, and headaches. K ϩ effluxes are reduced, prolonging the falling or repolarization phase of the action potential (Fig. 3) . This loss of function mutation induces repetitive nerve firing, causing excessive and unregulated neurotransmitter release at the neuromuscular junction (1). Neurotransmitters stimulate the skeletal muscle to produce ataxia and myokymia. In contrast, Andersen's syndrome is caused by a loss of function mutation reducing the K ir current that is involved in returning the membrane potential from hyperpolarization to resting (8) . These defects in K ir channels lead to difficulty in restimulating the muscle and episodic muscle weakness. Ϫ influxes, smaller influxes of Na ϩ are needed to reach threshold and trigger action potentials, and thus muscle excitability is enhanced (1) (Fig. 4) . There are two types of loss of function mutations of Cl Ϫ channels that cause myotonia. The dominant form of myotonia congenita is also known as Thomsen's disease, and the recessive form of generalized myotonia is known as Becker's disease. Myotonia congenita usually has low Cl Ϫ conductances and hyperexcitability exhibited as muscle cramping with exercise. Patients with myotonic dystrophy exhibit increased excitability of the muscle membrane due to loss (underexpression) of Cl Ϫ channels (1) . Congenital myasthenic syndromes are related to defects in neuromuscular transmission. Mutations in genes that encode the various subunits of nicotinic AChRs in skeletal muscle are known to cause either slow channel syndrome or fast channel syndrome. Slow channel syndrome is caused by a gain of function mutation in the AChR. Symptoms of slow channel syndrome include muscle weakness, rapid muscle fatigue, progressive muscle atrophy, and repetitive muscle action potentials from a single nerve stimulus (1) . Mutations in the AChR appear to result in prolonged channel activation by ACh. The increased duration of channel opening of the AChR leads to prolonged excitatory postsynaptic potentials and prolonged depolarization of the muscle membrane. Prolonged depolarization inactivates voltage-gated Na ϩ channels (depolarization block) and leads to failure of muscle excitability, thus resulting in muscle weakness and rapid fatigue. Fast channel syndrome with clinical features similar to slow channel syndrome is due to a reduction in ACh affinity and decreased rate of channel opening (1). Thus, fast channel syndrome is due to a loss of function change in the AChR. Fewer receptors are activated, and those activated are open for shorter periods, leading to reduced excitatory postsynaptic current and potential changes and a failure to elicit an action potential in the muscle cell.
Cl
Mutations in AChRs
Ca 2ϩ Channelopathies
Skeletal muscle channelopathies due to defects in Ca 2ϩ channels include hypokalemic periodic paralysis (HypoPP) (Fig. 6 ) and malignant hyperthermia (1 (1) . Individuals with MH only show evidence of the disorder when it is triggered by inhalation anesthetics or muscle relaxants. Increased cytoplasmic Ca 2ϩ leads to accelerated skeletal muscle metabolism, sustained muscle contractions, hyperkalemia, cardiac arrhythmias, respiratory and metabolic acidosis, and a body temperature that rises rapidly (hyperthermia) (1) . Body temperature may increase by 1°C every 5 min and can exceed 43°C. The antidote for the MH-induced increase in body temperature is dantrolene sodium, which blocks SR Ca 2ϩ release.
Autoantibodies Affecting Neuromuscular Transmission
Some common neuromuscular diseases that have been identified to be due to autoantibody formation are myasthenia gravis, Lambert-Eaton myasthenic syndrome (LEMS), and acquired neuromyotonia (1) . Autoantibodies may be made to channel proteins that lead to downregulation or upregulation of channel function (1) . In myasthenia gravis, there is a loss of functional AChRs in the skeletal muscle membrane due to the formation of antibodies against nicotinic AChRs in the postsynaptic membrane (1). Thus, with fewer AChR to be activated, end plate potentials are greatly reduced, and muscle weakness and fatigue result. This profound weakness of skeletal muscle generally increases with exercise. Muscle weakness of myasthenia gravis usually first appears in facial and eye muscles and later progresses to weakness in the limbs so that the patient has difficulty standing up or climbing stairs. LEMS is due to decreased ACh release from the presynaptic motoneurons caused by the production of antibodies against the P/Qtype voltage-gated Ca 2ϩ channels (1). These antibodies lead to a marked reduction in ACh release and failure of neuromuscular transmission, resulting in muscle weakness. In LEMS, muscle weakness is most common in the limbs, and patients have difficulty walking. Muscle weakness does not increase with exercise; in fact, muscle strength can be briefly enhanced by maximal effort. In 60% of patients with LEMS, small cell carcinoma of the lung is also present. It is thought that voltage-gated Ca 2ϩ channels in the tumor cause autoantibodies to be produced that block voltage-gated Ca 2ϩ channels at the nerve terminal. Acquired neuromyotonia is associated with antibodies against K v channels in neurons. Loss (underexpression) of K ϩ channels causes decreased K ϩ conductance and lengthens the repolarization phase of the action potential, thus enhancing neurotransmitter release (1) . Symptoms of acquired neuromyotonia include hypexcitability of motor nerves, leading to spontaneous muscle twitching (myokymia), muscle cramps, and muscle weakness (1) . The myotonia is spontaneous, continuous, and not stimulated by exercise.
Summary
Resting membrane potential in neurons is determined by differences in ion conductances through voltage-gated Na ϩ channels, delayed rectifier voltage-gated K ϩ channels, and Cl Ϫ channels. When a neuron is activated to threshold for opening voltage-gated Na ϩ channels, an action potential is initiated. During an action potential spike, once again, voltage-gated Na ϩ channels and delayed rectifier voltage-gated K ϩ channels are the primary channel players; however, at later times in recovery from an action potential, K Ca and K ir channels appear to be involved. Propagating neuronal action potentials depolarize the membrane at the axon terminal to open P/Q-type voltage-gated Ca 2ϩ channels that cause the secretion of ACh from vesicles into the synaptic cleft. ACh binds to the AChR at the end plate on the skeletal muscle cell, which opens the cation-selective pores of the AChR to depolarize the muscle cell to threshold for adjacent voltage-gated Na ϩ channels that initiate an action potential spike in the muscle cell. Action potentials propagate along the sarcolemma down t-tubules and activate L-type Ca 2ϩ channels there that activate Ca 2ϩ -release channels in the nearby SR, causing increased levels of free sarcoplasmic Ca 2ϩ and thus excitation-contraction coupling. Channelopathies (caused either by mutations or autoantibodies) involving many of these channels have been identified to lead to either diseases or disorders. Studying humans with these conditions has helped to elucidate the normal actions of ion channels in neuromuscular function (Table 1) .
